Related references
Note: Only part of the references are listed.Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
Mara Persano et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
Bernhard Scheiner et al.
JHEP REPORTS (2023)
Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab
Gabriel T. Schnickel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade
Robin Kate Kelley et al.
BRITISH JOURNAL OF CANCER (2022)
Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation
Min Kyung Park et al.
DIGESTIVE DISEASES AND SCIENCES (2022)
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Recent advances in systemic therapy for hepatocellular carcinoma
Huajun Zhang et al.
BIOMARKER RESEARCH (2022)
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial
Anthony B. El-Khoueiry et al.
BMC CANCER (2022)
AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma
Grace L. Su et al.
GASTROENTEROLOGY (2022)
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment
Ching-Tso Chen et al.
HEPATOLOGY INTERNATIONAL (2022)
Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma
Shigeo Shimose et al.
SCIENTIFIC REPORTS (2022)
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis
Catherine Leyh et al.
CANCERS (2022)
Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function
Jasmine Huynh et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
Yeong Hak Bang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience
Tiago de Castro et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)
Systemic treatment of hepatocellular carcinoma: An EASL position paper
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2021)
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
A. Vogel et al.
ANNALS OF ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
Laura Crocetti et al.
CANCERS (2021)
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
Masatoshi Kudo et al.
JOURNAL OF HEPATOLOGY (2021)
Surgical treatment of hepatocellular carcinoma
Yasuhiko Sugawara et al.
BIOSCIENCE TRENDS (2021)
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
Kaoru Tsuchiya et al.
CANCERS (2021)
Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
Daniel Azoulay et al.
JHEP REPORTS (2021)
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Fabian Finkelmeier et al.
LIVER CANCER (2021)
A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer
Ruben Ciria et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2020)
Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child-Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
Qingquan Zu et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department
Si-Zhe Wan et al.
DISEASE MARKERS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effectiveness and Safety of Nivolumab in Child-Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study
Won-Mook Choi et al.
CANCERS (2020)
Safety and Efficacy of Lenvatinib Treatment in Child-Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis
Katsuaki Ogushi et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2020)
Liver Transplantation in France
Francois Durand et al.
LIVER TRANSPLANTATION (2019)
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentrereal- world cohort
Bernhard Scheiner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Liver transplantation for hepatocellular carcinoma: Where do we stand?
Francesco Santopaolo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study
Rebecca A. Miksad et al.
BMC CANCER (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis
Pin-Cheng Chen et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
Qiuhe Wang et al.
JOURNAL OF HEPATOLOGY (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
90Y Radioembolization for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort
Nadine Abouchaleh et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults
Christopher D. Woodrell et al.
CLINICAL THERAPEUTICS (2018)
Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study
Cassia Regina Guedes Leal et al.
INVESTIGATIONAL NEW DRUGS (2018)
Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals
Felix Krenzien et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Locoregional therapy as a bridge to liver transplantation for hepatocellular carcinoma within Milan criteria: from a transplant oncology viewpoint
Taizo Hibi et al.
HEPATOBILIARY SURGERY AND NUTRITION (2018)
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
Giorgia Marisi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma-a meta-analysis
Mairead Geraldine McNamara et al.
EUROPEAN JOURNAL OF CANCER (2018)
Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
Andrea Casadei Gardini et al.
ONCOTARGETS AND THERAPY (2018)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same?
Martina Coletta et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies
Ying Peng et al.
MEDICINE (2016)
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
Young Youn Cho et al.
PLOS ONE (2016)
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
Davide Citterio et al.
JAMA SURGERY (2016)
Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis
Satoshi Kitai et al.
LIVER CANCER (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Management of patients with decompensated cirrhosis
Phillip M. Harrison
CLINICAL MEDICINE (2015)
Laparoscopic versus open liver resection for hepatocellular carcinoma: Case-matched study with propensity score matching
Ho-Seong Han et al.
JOURNAL OF HEPATOLOGY (2015)
Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives
Rodolfo Sacco et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
R. Lencioni et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Treatment of Hepatocellular Carcinoma with Child-Pugh C Cirrhosis
Kazuhiro Nouso et al.
ONCOLOGY (2014)
Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function
David P. Dorn et al.
HPB (2014)
Role of Supportive Care for Terminal Stage Hepatocellular Carcinoma
Manoj Kumar et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Treatment of hepatocellular carcinoma in Child-Pugh B patients
Fabio Piscaglia et al.
DIGESTIVE AND LIVER DISEASE (2013)
Hepatocellular Carcinoma in Child-Pugh C Cirrhosis: Prognostic Factors and Survival Benefit of Nontransplant Treatments
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2013)
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: Impact of liver function on systemic treatment options at disease progression
Khairuddin Memon et al.
JOURNAL OF HEPATOLOGY (2013)
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction
Elisabeth R. Garwood et al.
LIVER TRANSPLANTATION (2013)
Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines
Kenichi Takayasu et al.
JOURNAL OF HEPATOLOGY (2012)
Clinical course of sorafenib treatment in patients with hepatocellular carcinoma
Hyun Young Woo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score
Hyun Chin Cho et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis
K. Nouso et al.
BRITISH JOURNAL OF CANCER (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: Evaluation of therapeutic efficacy and safety
YK Kim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list
FY Yao et al.
LIVER TRANSPLANTATION (2002)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Share Paper
